Target intelligence / Profile preview

Auricular chondrocyte

Molecular classification
Cell type
01

Overview

Auricular chondrocytes are the specialized resident cells of the elastic cartilage found in the pinna of the external ear. Their primary biological function is the synthesis and maintenance of a unique extracellular matrix characterized by a high density of elastic fibers and type II collagen, which provides the ear with its essential flexibility and structural memory (Source: PubMed, PMID: 17091757). While they are not traditional molecular drug targets like receptors or enzymes, they are the fundamental units of interest in regenerative medicine and tissue engineering for treating congenital deformities such as microtia or traumatic injuries (Source: ScienceDirect). In autoimmune conditions like relapsing polychondritis, these cells and their surrounding matrix are the primary site of inflammation and tissue destruction (Source: StatPearls). Research into these cells often focuses on their superior ability to maintain a chondrogenic phenotype compared to articular chondrocytes when expanded in vitro for reconstructive surgery (Source: Journal of Tissue Engineering and Regenerative Medicine). Therapeutic interventions typically involve the use of growth factors to stimulate these cells to regenerate or repair damaged auricular frameworks.

Other names
Ear cartilage cellElastic cartilage cellAuricular cartilage cell
02

Mechanism of action

Not applicable as this is a cell type rather than a molecular target; however, therapeutic growth factors interact with surface receptors on these cells to modulate proliferation and extracellular matrix production.

03

Biological functions

Extracellular matrix synthesisElastogenesisCartilage maintenanceStructural support
04

Disease associations

MicrotiaRelapsing polychondritisCauliflower ear (Hematoma auris)Cartilage defects
05

Safety considerations

Dedifferentiation during in vitro expansionDonor site morbidity during harvestingRisk of calcification or fibrosis in tissue engineering applications
06

Interacting drugs

Transforming growth factor beta

2 more in the full profile.

07

Biomarkers

Collagen type IIElastinSOX9AggrecanCD44

Beyond the preview

Go deeper on Auricular chondrocyte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Auricular chondrocyte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call